CoChat
Sign Up
Cited by 28

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs

Jawa, Raagini, Stein, Michael D., Anderson, Bradley, Liebschutz, Jane M., Stewart, Catherine, Phillips, Kristina T., Barocas, Joshua A.·2021·International Journal of Drug Policy
DOI 10.1016/j.drugpo.2021.103198PMC PMC8373634
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drugpo.2021.103198

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 60

  1. Abadie, 2016, Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico, Harm Reduction Journal, 13, 10, 10.1186/s12954-016-0099-9 · DOI
  2. Ball, 2019, Sharing of injection drug preparation equipment is associated with HIV infection: A cross-sectional Study, Journal of Acquired Immune Deficiciency Syndrome, 81, e99, 10.1097/QAI.0000000000002062 · DOI
  3. Ball, 2019, Heating injection drug preparation equipment used for opioid injection may reduce HIV transmission associated with sharing equipment, Journal of Acquired Immune Deficiency Syndrome, 81, e127, 10.1097/QAI.0000000000002063 · DOI
  4. Bassetti, 2002, Infections requiring hospitalization of injection drug users who participated in an injection opiate maintenance program, Clinical Infectious Diseases, 34, 711, 10.1086/338876 · DOI · Paper page
  5. Bravo, 2009, Use of supervised injection facilities and injection risk behaviours among young drug injectors, Addiction, 104, 614, 10.1111/j.1360-0443.2008.02474.x · DOI
  6. Broz, 2014, HIV infection and risk, prevention, and testing behaviors among injecting drug users – National HIV behavioral surveillance system, 20 U.S. cities, 2009, Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C.: 2002), 63, 1
  7. 2020, HIV infection risk, prevention, and testing behaviors among persons who inject drugs—National HIV behavioral surveillance: injection drug use, 23 U.S. Cities, 2018, HIV Surveillance Special Report, 24, Page 43
  8. Ciccarone, 2016, Nationwide increase in hospitalizations for heroin-related soft tissue infections: Associations with structural market conditions, Drug and Alcohol Dependence, 163, 126, 10.1016/j.drugalcdep.2016.04.009 · DOI
  9. Dahlman, 2017, Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: A community-based observational study, Substance Abuse, 38, 105, 10.1080/08897077.2016.1263592 · DOI
  10. Darke, 2001, Geographical injecting locations among injecting drug users in Sydney, Australia, Addiction, 96, 241, 10.1046/j.1360-0443.2001.9622416.x · DOI
  11. Des Jarlais, 1999, Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial, Lancet, 353, 1657, 10.1016/S0140-6736(98)07026-3 · DOI
  12. Doran, 2020, Factors associated with skin and soft tissue infections among people who inject drugs in the United Kingdom: A comparative examination of data from two surveys, Drug and Alcohol Dependence, 213, 10.1016/j.drugalcdep.2020.108080 · DOI · Paper page
  13. Dunleavy, 2019, The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: A qualitative study, International Journal of Drug Policy, 65, 65, 10.1016/j.drugpo.2018.09.001 · DOI
  14. Dunleavy, 2017, Association between harm reduction intervention uptake and skin and soft tissue infections among people who inject drugs, Drug and Alcohol Dependence, 174, 91, 10.1016/j.drugalcdep.2017.01.020 · DOI
  15. Dwyer, 2009, Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users, Drug and Alcohol Dependence, 100, 9, 10.1016/j.drugalcdep.2008.08.016 · DOI · Paper page
  16. Fairbairn, 2008, Seeking refuge from violence in street-based drug scenes: Women's experiences in North America's first supervised injection facility, Social Science & Medicine (1982), 67, 817, 10.1016/j.socscimed.2008.05.012 · DOI
  17. Fink, 2013, Abscess and self-treatment among injection drug users at four California syringe exchanges and their surrounding communities, Substance Use & Misuse, 48, 523, 10.3109/10826084.2013.787094 · DOI · Paper page
  18. Geddes, 2018, Intravenous fentanyl use among people who inject drugs in Australia, Drug and Alcohol Review, 37, S314
  19. Gordon, 2005, Bacterial infections in drug users, New England Journal of Medicine, 353, 1945, 10.1056/NEJMra042823 · DOI · Paper page
  20. Greenfield, 1995, Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors, Drug and Alcohol Dependence, 39, 91, 10.1016/0376-8716(95)01155-R · DOI
  21. Hagan, 2001, Sharing of drug preparation equipment as a risk factor for hepatitis C, American Journal of Public Health, 91, 42, 10.2105/AJPH.91.1.42 · DOI
  22. Hope, 2015, Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England, Epidemiology and Infection, 143, 120, 10.1017/S0950268814000284 · DOI
  23. Hope, 2015, Going into the groin: Injection into the femoral vein among people who inject drugs in three urban areas of England, Drug and Alcohol Dependence, 152, 239, 10.1016/j.drugalcdep.2015.03.029 · DOI
  24. Irvine, 2019, Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic, Addiction, 114, 1602, 10.1111/add.14664 · DOI
  25. Irwin, 2017, Mitigating the heroin crisis in Baltimore, MD, USA: A cost-benefit analysis of a hypothetical supervised injection facility, Harm Reduction Journal, 14, 29, 10.1186/s12954-017-0153-2 · DOI
  26. Iversen, 2015, HIV, HCV, and health-related harms among women who inject drugs: Implications for prevention and treatment, Journal of Acquired Immune Deficiency Syndrome, 69, S176, 10.1097/QAI.0000000000000659 · DOI
  27. Kasper, 2019, A controlled-release oral opioid supports S. aureus survival in injection drug preparation equipment and may increase bacteremia and endocarditis risk, PloS One, 14, 10.1371/journal.pone.0219777 · DOI
  28. Kerr, 2007, The role of safer injection facilities in the response to HIV/AIDS among injection drug users, Current HIV/AIDS Reports, 4, 158, 10.1007/s11904-007-0023-8 · DOI
  29. Kerr, 2005, Safer injection facility use and syringe sharing in injection drug users, Lancet, 366, 316, 10.1016/S0140-6736(05)66475-6 · DOI · Paper page
  30. Koester S., 1994, “Indirect sharing”: Additional HIV risks associated with drug injection, AIDS and Public Policy Journal, 9, 100
  31. Koester, 2005, Drug sharing among heroin networks: Implications for HIV and hepatitis B and C prevention, AIDS and Behavior, 9, 27, 10.1007/s10461-005-1679-y · DOI
  32. Lambdin, 2019, Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs, International Journal of Drug Policy, 74, 299, 10.1016/j.drugpo.2019.10.004 · DOI
  33. Larney, 2017, A systematic review of injecting-related injury and disease among people who inject drugs, Drug and Alcohol Dependence, 171, 39, 10.1016/j.drugalcdep.2016.11.029 · DOI · Paper page
  34. Liebschutz, 2014, Buprenorphine treatment for hospitalized, opioid-dependent patients: A randomized clinical trial, JAMA Internal Medicine, 174, 1369, 10.1001/jamainternmed.2014.2556 · DOI
  35. Macalino, 2002, Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users, AIDS Education and Prevention : Official Publication of the International Society for AIDS Education, 14, 367, 10.1521/aeap.14.6.367.24075 · DOI
  36. Marks, 2013, Needles and the damage done: Reasons for admission and financial costs associated with injecting drug use in a Central London Teaching Hospital, Journal of Infection, 66, 95, 10.1016/j.jinf.2012.10.004 · DOI · Paper page
  37. McCoy, 1998, Parenteral transmission of HIV among injection drug users: Assessing the frequency of multiperson use of needles, syringes, cookers, cotton, and water, Journal of Acquired Immune Deficiency Syndrome Human Retrovirology, 18, S25, 10.1097/00042560-199802001-00006 · DOI
  38. McLellan, 1992, The fifth edition of the addiction severity index, Journal of Substance Abuse Treatment, 9, 199, 10.1016/0740-5472(92)90062-S · DOI
  39. Palepu, 2001, Hospital utilization and costs in a cohort of injection drug users, CMAJ: Canadian Medical Association Journal = Journal de l'Association Medicale Canadienne, 165, 415
  40. Phillips, 2016, Barriers to practicing risk reduction strategies among people who inject drugs, Addiction Research & Theory, 24, 62, 10.3109/16066359.2015.1068301 · DOI
  41. Phillips, 2013, Development of a risk reduction intervention to reduce bacterial and viral infections for injection drug users, Substance Use & Misuse, 48, 54, 10.3109/10826084.2012.722159 · DOI
  42. Phillips, 2017, Risk factors associated with skin and soft tissue infections among hospitalized people who inject drugs, Journal of Addiction Medicine, 11, 461, 10.1097/ADM.0000000000000346 · DOI
  43. Phillips, 2010, Risk practices associated with bacterial infections among injection drug users in Denver, Colorado, American Journal of Drug and Alcohol Abuse, 36, 92, 10.3109/00952991003592311 · DOI
  44. Phillips, 2012, Skin and needle hygiene intervention for injection drug users: Results from a randomized, controlled Stage I pilot trial, Journal of Substance Abuse Treatment, 43, 313, 10.1016/j.jsat.2012.01.003 · DOI
  45. Phillips, 2020, A randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugs, Drug and Alcohol Dependence, 221, 108646, 10.1016/j.drugalcdep.2021.108646 · DOI · Paper page
  46. Raff, 2016, Cellulitis: A review, Journal of the American Medical Association, 316, 325, 10.1001/jama.2016.8825 · DOI
  47. Rivera, 2014, Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010-2012, Drug and Alcohol Dependence, 144, 259, 10.1016/j.drugalcdep.2014.09.778 · DOI
  48. Roy, 2016, Prevalence and correlates of prescription opioid residue injection, Drug and Alcohol Dependence, 166, 69, 10.1016/j.drugalcdep.2016.06.025 · DOI
  49. Roy, 2012, Injection of drug residue as a potential risk factor for HCV acquisition among Montreal young injection drug users, Drug and Alcohol Dependence, 126, 246, 10.1016/j.drugalcdep.2012.05.018 · DOI
  50. Salmon, 2009, Injecting-related injury and disease among clients of a supervised injecting facility, Drug and Alcohol Dependence, 101, 132, 10.1016/j.drugalcdep.2008.12.002 · DOI
  51. Shah, 2020, Risk factors of infective endocarditis in persons who inject drugs, Harm Reduction Journal, 17, 35, 10.1186/s12954-020-00378-z · DOI
  52. Shah, 1996, Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: A preliminary laboratory report, Journal of Acquired Immune Deficiency Syndrome Human Retrovirology, 11, 301, 10.1097/00042560-199603010-00010 · DOI
  53. Sharma, 2017, Harm reduction in hospitals, Harm Reduction Journal, 14, 32, 10.1186/s12954-017-0163-0 · DOI
  54. Stein, 2020, Skin-cleaning among hospitalized people who inject drugs: A randomized controlled trial, Addiction
  55. Thakarar, 2020, Harm reduction services to prevent and treat infectious diseases in people who use drugs, Infectious Disease Clinics of North America, 34, 605, 10.1016/j.idc.2020.06.013 · DOI
  56. Tran, 2020, Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis, International Journal of Drug Policy, 84, 10.1016/j.drugpo.2020.102866 · DOI
  57. Van Handel, 2016, County-level vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs, United States, Journal of Acquired Immune Deficiency Syndrome, 73, 323, 10.1097/QAI.0000000000001098 · DOI
  58. Whiteman, 2020, Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17U.S. cities, 2015, International Journal of Drug Policy, 85, 10.1016/j.drugpo.2020.102923 · DOI
  59. Zibbell, 2014, Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics, American Journal of Public Health, 104, 2226, 10.2105/AJPH.2014.302142 · DOI
  60. Zibbell, 2015, Increases in hepatitis C virus infection related to injection drug use among persons aged </=30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012, MMWR Morbidity and Mortality Weekly Report, 64, 453

Cited by

Sorted by citations

See all 28

Metadata

Authors
Jawa, R., Stein, M. D., Anderson, B., Liebschutz, J. M., Stewart, C., Phillips, K. T., & Barocas, J. A.
Venue
International Journal of Drug Policy
Publisher
Elsevier BV
Published
2021-08
Volume
94
Pages
103198
ISSN
0955-3959
DOI
10.1016/j.drugpo.2021.103198
PMC
PMC8373634
Cited by
28
References
8
Language
en
Licence
Funders
  • NIH
  • National Institute on Drug Abuse (DP2DA51864, K01DA051684, R01DA034957, R25DA033211)
  • National Institute of Allergy and Infectious Diseases (T32AI052074)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review